Navigation Links
Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
Date:8/4/2008

female patients and female partners of male patients exposed to ribavirin during treatment, and for 6 months following cessation of treatment. Physicians and patients are encouraged to report such cases by calling 1-800-593-2214.

Incidence of Adverse Events

There are no new adverse events specific to PEGINTRON as compared to INTRON A; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. The most common adverse events associated with PEGINTRON were "flu-like" symptoms, occurring in approximately 50% of patients, which may decrease in severity as treatment continues. Application site disorders were common (47%), but all were mild (44%) or moderate (4%) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving PEGINTRON. Alopecia (thinning of the hair) is also often associated with alpha interferons including PEGINTRON.

Psychiatric adverse events, which include insomnia, were common (57%) with PEGINTRON but similar to INTRON A (58%). Depression was most common at 29%. Suicidal behavior including ideation, suicidal attempts, and completed suicides occurred in 1% of patients during or shortly after completing treatment with PEGINTRON.

The following serious or clinically significant adverse events have been reported at a frequency less than 1% with PEGINTRON or interferon alpha: Severe decreases in neutrophil or platelet counts, hypothyroidism, hyperglycemia, hypotension, arrhythmia, ulcerative and hemorrhagic colitis, development or exacerbation of autoimmune disorders including thyroiditis, RA, systemic lupus erythematosus, psoriasis, pulmonary disorders (dyspnea, pulmonary infiltrates, pneumonitis and pneumonia, some resulting in patient deaths), urticaria, angioedema, bronchoconstriction, anaphylaxis, retinal hemorrhages, and cotton wool spots.

In the PEGINTRON/RE
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
2. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
3. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
4. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
5. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
6. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
9. Schering-Plough Reports Top-Line Results of the IDEAL Study
10. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
11. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the ... detection of pathogenic bacteria, including potential bioterrorism agents ... Bacillus anthracis which feature on the Center ... bio-threats. This seminal study, conducted in collaboration with ... Salisbury (DSTL), United Kingdom ...
(Date:5/20/2013)... YORK , May 20, 2013  Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence.  The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... Mai 2013 Sequent Medical, Inc. ... CE-Kennzeichnung für die SL-Produktfamilie („Single Layer") seiner ... hat. Das Unternehmen hat in ausgewählten neurovaskulären ... Einführung dieser neuen Modelle begonnen. Neben einem ... verbessertes Handling, das es Ärzten ermöglicht, ein ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3
... Dec. 16, 2010 Watson Pharmaceuticals, Inc. (NYSE: ... today announced that Watson,s subsidiary, Watson Laboratories, Inc. has ... ("Preglem") the wholly owned subsidiary of Richter, to develop ... Canada.  In European studies, Esmya™ has been shown to ...
... announced today the award recipients from its November Virtual ... March of Dimes, National Prematurity Awareness Month. This year ... Neonatal Intensive Care Unit. In addition, the number of ... six in 2010.  Each of the following hospitals will ...
Cached Medicine Technology:Watson and Richter Announce Exclusive License Agreement for Esmya™ 2Watson and Richter Announce Exclusive License Agreement for Esmya™ 3Watson and Richter Announce Exclusive License Agreement for Esmya™ 4Watson and Richter Announce Exclusive License Agreement for Esmya™ 5Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2010 Prematurity Awareness Month 2
(Date:5/20/2013)... May 20, 2013 Fastcare Miami Beach ... infection (UTI) within its first symptoms, as if not treated, ... a more serious infection. Although a urinary tract infection in ... lead to serious kidney infection called pyelonephritis. Women seem to ... come up to the same percentage as women after the ...
(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... been released to the public creating a frenzy ... access to this elite business training. WealthSpringMarketing.com's Tiffany ... as well as an exclusive bonus. , "Eben ... providing elite business training to individuals serious about ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Parker Waichman ... rights of victims injured by defective drugs, has filed ... who alleges that use of the diabetes drug medication ... was filed on April 30, 2013, in the U.S. ... No. 6:13-cv-0888), where it is one of thousands of ...
(Date:5/20/2013)... Leading facial plastic surgeon and ENT specialist Dr. ... Doc” in the field of Otolaryngology in the May/June 2013 ... Beacher magazine, one of Palm Beach County’s leading lifestyle publications, ... 2013 issue, including 70 of the very best physicians in ... to do, health and fitness, people to watch, top doctors, ...
Breaking Medicine News(10 mins):Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
... meditation training are associated with greater telomerase activity, according ... the University of California, San Francisco. The study is ... an enzyme important for the long-term health of cells ... attributable to psychological changes that increase a person,s ability ...
... Nov. 3 Stereotactic body radiotherapy (SBRT), a radiation ... Institute (UPCI) that precisely delivers a large dose of ... and neck cancers when combined with the chemotherapy Cetuximab, ... research will be presented today at the American Society ...
... suggests that older adults who wear multifocal contact lenses ... condition that increases with age, may have greater difficulty ... Age-related problems with near vision, medically termed presbyopia, usually ... the inability to focus on objects up close. ...
... HealthDay Reporter , WEDNESDAY, Nov. 3 (HealthDay News) -- ... between asthma and lung cancer in a small study. ... pulmonary disease (COPD) and lung cancer, but this is the ... and lung cancer, the researchers said. However, based on ...
... professionals, has been selected to serve as a partner ... beginning Sept. 21, 2010. A coalition of 48 ... reconstitute the NPP, which currently comprises 32 organizations working ... The NPP,s previous work has targeted ways to eliminate ...
... Calif., Nov. 3, 2010 The U.S. Department of Veterans ... scientist the highest honor it bestows on scientists. ... Department of Orthopaedic Surgery, will receive $1.4 million to support ... Beach VA Medical Center. "Dr. Lee is one of ...
Cached Medicine News:Health News:Positive psychological changes from meditation training linked to cellular health 2Health News:Positive psychological changes from meditation training linked to cellular health 3Health News:Combining radiation therapy, chemotherapy safely treats head and neck cancer patients 2Health News:Multifocal contact lenses may reduce vision for night driving 2Health News: Asthma Linked to Lung Cancer Risk in Study 2Health News:National Quality Forum picks AMIA for national priorities partnership 2Health News:VA names UCI orthopedic biomedical engineer a senior research career scientist 2
TC-98 elisa strip reader. Reads, calculates, and prints results for up to 12 wells in about 30 seconds. Single point calibration. Multi-point calibration....
... Personal Plate Shaker with Timer are designed ... of 96 & 384-well microplates. The on/off button, ... located on the side of the unit. The ... the unit for adjustment of speed from a ...
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
... flow cytometer for all applications in Cytomics ... absolute counting. The CyFlow ML allows to ... signals in combination with up to 13 ... can perform in a wide variety of ...
Medicine Products: